Related Experiment Video

Updated: Jul 19, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice

Shailja V Parikh1, James A de Lemos

  • 1Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9047, USA.

The American Journal of the Medical Sciences
|October 13, 2006
PubMed

Insights

Biomarkers are crucial for diagnosing and managing acute coronary syndromes (ACS). Combining multiple biomarkers improves risk assessment and guides personalized treatment strategies for better patient outcomes.

Area of Science:

  • Cardiology
  • Biochemistry
  • Proteomics

Background:

  • Biomarkers are essential for diagnosing, assessing prognosis, and managing patients with acute coronary syndromes (ACS).
  • Specific biomarkers indicate distinct pathophysiologic processes in ACS, including myocyte necrosis (troponins), neurohormonal activation (natriuretic peptides), platelet activation (soluble CD40 ligand), and inflammation (C-reactive protein, myeloperoxidase, monocyte chemoattractant protein-1).

Purpose of the Study:

  • To highlight the role of various biomarkers in acute coronary syndromes (ACS).
  • To emphasize the benefit of using combined biomarkers for enhanced risk stratification in ACS.
  • To discuss the potential of novel biomarkers and proteomic technologies in tailoring ACS therapy.

Main Methods:

  • Review of current literature on biomarkers in ACS.
  • Analysis of the pathophysiologic relevance of established biomarkers.
  • Discussion of emerging proteomic technologies for biomarker discovery.

Main Results:

  • Individual biomarkers like troponins, natriuretic peptides, soluble CD40 ligand, C-reactive protein, myeloperoxidase, and monocyte chemoattractant protein-1 reflect specific ACS pathways.
  • Combined use of multiple biomarkers significantly enhances risk stratification compared to single markers.
  • Proteomic advancements are expected to yield new biomarkers for ACS diagnosis and treatment selection.

Conclusions:

  • Multiple biomarkers reflecting diverse pathophysiologic processes are vital for comprehensive ACS management.
  • Combining biomarkers offers superior risk stratification in ACS.
  • Future research focusing on novel biomarkers and proteomic technologies will enable personalized ACS treatment strategies.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...